Endava (DAVA) Earnings Analysis
Endava (DAVA) next reports earnings on 2026-09-03, consensus EPS 0.15 USD. Last quarter (2026-05-21) it missed with EPS 0.07 USD vs 0.27 USD est (-74.1%). It has beaten estimates in 3/6 recent quarters (50%). Trailing P/E -0.26.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does DAVA next report earnings?
| Next earnings date | 2026-09-03 |
|---|---|
| Consensus EPS estimate | 0.15 USD |
| Revenue estimate | 0.24B |
DAVA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-21 | 0.07 USD | 0.27 USD | -74.1% | Miss |
| 2026-02-19 | 0.21 USD | 0.21 USD | 0% | Beat |
| 2025-09-04 | 0.32 USD | 0.32 USD | 0% | Beat |
| 2025-05-14 | 0.2378 USD | 0.3984 USD | -40.3% | Miss |
| 2025-02-20 | 0.38 USD | 0.326 USD | +16.6% | Beat |
| 2024-09-19 | 0.28 USD | 0.2859 USD | -2.1% | Miss |
Beat rate: 3/6 (50%) over reported quarters with consensus data.
DAVA valuation and analyst view
| Trailing P/E | -0.26 |
|---|---|
| Trailing EPS | -7.98035 USD |
| Price / book | 0.62 |
| Dividend yield | 0.00% |
| Market cap | 0.15B |
| Analyst consensus | Hold (5 buy / 10 hold / 1 sell) |
| Avg price target | 4 USD |
Related research pages
Frequently asked questions
When is Endava (DAVA)'s next earnings date?
Endava is next scheduled to report on 2026-09-03, with a consensus EPS estimate of 0.15 USD and revenue estimate of 0.24B.
Did DAVA beat earnings last quarter?
In its 2026-05-21 report, DAVA posted EPS of 0.07 USD versus a 0.27 USD estimate — a miss of 74.1%.
What is DAVA's earnings track record?
Over the last 6 reported quarters with consensus data, DAVA beat estimates 3 times (50%).
What is DAVA's current P/E ratio and EPS?
DAVA trades at a trailing P/E of -0.26 on trailing EPS of -7.980354512742837 USD.
What do analysts rate DAVA?
Analyst consensus is "Hold" across 16 ratings (0 strong buy, 5 buy, 10 hold, 1 sell, 0 strong sell). Average 12-month price target: 4 USD.